Tourette's syndrome

Current Treatment Options in Neurology

Volumn 7, Issue 3, 2005, Pages 211-219

  Gilbert, Donald L ^a   Lipps, Tara D ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOGLYCOSIDE; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN; CENTRAL DEPRESSANT AGENT; CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; IMMUNOGLOBULIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; PENICILLIN G; PERGOLIDE; PIMOZIDE; PLACEBO; PSYCHOSTIMULANT AGENT; RISPERIDONE; ROPINIROLE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

AKATHISIA; ANAPHYLAXIS; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BODY WEIGHT DISORDER; BRAIN DEPTH STIMULATION; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOCTOR PATIENT RELATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; FUNCTIONAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HALLUCINATION; HUMAN; HYPOTENSION; IMPULSIVENESS; INJECTION SITE; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NAUSEA; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; ORTHOSTATIC HYPOTENSION; PAIN; PARESTHESIA; PRURITUS; PSYCHOTHERAPY; SEDATION; SEIZURE; SKIN IRRITATION; SOCIAL PROBLEM; SOMATIZATION; SOMNOLENCE; SYMPTOMATOLOGY; SYNCOPE; TARDIVE DYSKINESIA; TIC; TREATMENT PLANNING; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 21244475622     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0014-2     Document Type: Article

References (38)

1. Apter A, Pauls DL, Bleich A, et al.: An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 1993, 50:734-738.
2. Kurlan R, McDermott MP, Deeley C, et al.: Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001, 57:1383-1388.
3. Snider LA, Seligman LD, Ketchen BR, et al.: Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002, 110:331-336.
4. Robertson MM: Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
5. Gilbert DL, Buncher CR: Assessment of scientific and ethical issues in two randomized clinical trial designs for patients with Tourette Syndrome, as a model for studies of multiple neuropsychiatric diagnoses. J Neuropsychiatry Clin Neurosci 2005; In Press.
6. Swedo SE, Leonard HL, Garvey M, et al.: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264-271.
7. Perrin EM, Murphy ML, Casey JR, et al.: Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? [see comment]. Arch Pediatr Adolesc Med 2004, 158:848-856.
8. Tourette's Syndrome Study G: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527-536.
9. Scahill L, Chappell PB, Kim YS, et al.: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067-1074.
10. Cummings DD, Singer HS, Krieger M, et al.: Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 2002, 25:325-332.
11. Anca MH, Giladi N, Korczyn AD: Ropinirole in Gilles de la Tourette syndrome. Neurology 2004, 62:1626-1627.
12. Griesemer DA: Pergolide in the management of Tourette syndrome. J Child Neurol 1997, 12:402-403.
13. Lipinski JF, Sallee FR, Jackson C, et al.: Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 1997, 12:402-407.
14. Gilbert DL, Sethuraman G, Sine L, et al.: Tourette syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000, 54:1310-1315.
15. Gilbert DL, Dure L, Sethuraman G, et al.: Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606-611.
16. Gilbert D, Singer HS: Commentary: "Risperidone was as effective as pimozide for Tourette's disorder." EBMH 2001, 4:75.
17. Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130-1135.
18. Dion Y, Annable L, Sandor P, et al.: Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31-39.
19. Bruggeman R, Van DL, Buitelaar JK, et al.: Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001, 62:50-56.
20. Gilbert DL, Batterson JR, Sethuraman G, et al.: Tic reduction with risperidone vs. pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004, 43:206-214.
21. Gaffney GR, Perry PJ, Lund BC, et al.: Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330-336.
22. Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292-299.
23. Marras C, Andrews D, Sime E, et al.: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. [see comment]. Neurology 2001, 56:605-610.
24. Kwak CH, Hanna PA, Jankovic J: Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190-1193.
25. Lowe TL, Cohen DJ, Detlor J, et al.: Stimulant medications precipitate Tourette's syndrome. JAMA 1982, 247:1729-1731.
26. Anonymous: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999, 56:1073-1086.
27. American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity D and Committee on Quality I: Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. [see comment]. Pediatrics 2001, 108:1033-1044.
28. Group MTAC: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004, 113:762-769.
29. Coffey BJ, Allen AJ, Kurlan RM, et al.: Atomoxetine Treatment in Children with ADHD and Comorbid Tic Disorders. American Psychiatic Association Meeting, 2004.
30. Temel Y, Visser-Vandewalle V: Surgery in Tourette syndrome. Mov Disord 2004, 19:3-14.
31. Visser-Vandewalle V, Temel Y, Boon P, et al.: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003, 99:1094-1100.
32. Wilhelm S, Deckersbach T, Coffey BJ, et al.: Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry 2003, 160:1175-1177.
33. Verdellen CW, Keijsers GP, Cath DC, et al.: Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther 2004, 42:501-511.
34. The Pediatric OCD Treatment Study (POTS) Team: Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents with Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study (POTS) Randomized Controlled Trial. JAMA 2004, 292:1969-1976.
35. Garvey MA, Perlmutter SJ, Allen AJ, et al.: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45:1564-1571.
36. Perlmutter SJ, Leitman SF, Garvey MA, et al.: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood [see comments]. Lancet 1999, 354:1153-1158.
37. Munchau A, Bloem BR, Thilo KV, et al.: Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology 2002, 59:1789-1791.
38. Chae JH, Nahas Z, Wassermann E, et al.: A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol 2004, 17:109-117.